
|Articles|October 27, 2021
Imaging Endpoints Establishes Operations in Shanghai
Advertisement
Imaging Endpoints has announced that it has established a new office in Shanghai, China, home to rapidly growing pharmaceutical and biotech innovations in Asia. Imaging Endpoints has expanded its globality to include eight offices across six countries and three continents.
Imaging Endpoints works with nearly all imaging sites globally that participate in clinical trials, and the expansion of operations into Shanghai will enable key team members, such as project managers and radiology experts, to work real-time with their counterparts in China and throughout the Pacific Rim.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
2026 DIA Global Annual Meeting: Why Protocol Digitization Has Been So Hard to Automate—Until Now
2
2026 DIA Global Annual Meeting: What Drives Sponsors to Mixed Outsourcing Models and What the Transition Looks Like
3
Tapping the Global Potential of China’s Biotech Surge
4
2026 DIA Global Annual Meeting: What the FDA's Real-Time Data Push Actually Means for Sponsors and CROs
5




